The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 346:2087-2088 June 27, 2002 Number 26
NextNext

Monoclonal Gammopathy of Undetermined Significance

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Kyle, R. A.
-PubMed Citation
To the Editor: In their long-term follow-up study of patients with monoclonal gammopathy of undetermined significance (MGUS), Kyle et al. (Feb. 21 issue)1 did not include patients with pure Bence Jones proteinuria, resulting from a plasma-cell dyscrasia involving the excretion of monoclonal light chains into the urine. From a pathophysiological point of view, it is reasonable to include light-chain disease in MGUS, since it clearly also represents a gammopathy.2 Although the disorder is clinically relevant, there is astonishingly little information in the literature on the prognosis for patients with pure, idiopathic Bence Jones proteinuria.3,4 Before 1980, it was not recognized . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.